Equities

Inspira Technologies Oxy BHN Ltd

IINN:NAQ

Inspira Technologies Oxy BHN Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)2.30
  • Today's Change-0.02 / -0.86%
  • Shares traded109.93k
  • 1 Year change+61.97%
  • Beta--
Data delayed at least 15 minutes, as of May 31 2024 21:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Inspira Technologies Oxy B.H.N Ltd, formerly Insense Medical Ltd, incorporated on February 27, 2018, is a specialty medical device company based in Israel. The Company is engaged in the research, development, manufacture, and marketing of respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV). It provides patients with acute respiratory distress syndrome to maintain spontaneous breathing and avoid the various risks associated with the use of MV.

  • Revenue in USD (TTM)0.00
  • Net income in USD-11.29m
  • Incorporated2018
  • Employees37.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Co-Diagnostics Inc6.68m-38.89m32.84m155.00--0.4192--4.92-1.32-1.320.22682.510.06561.144.2643,083.48-38.195.77-39.936.1541.3482.24-582.3610.949.90--0.000.00-80.09179.54-148.15--101.27--
Akili Inc1.95m-48.55m33.11m36.00--0.6592--17.00-0.6201-0.62010.02490.63810.0203--20.1928,647.06-50.58---57.34--56.11---2,492.04-----25.510.1835--419.50---212.48------
Harvard Apparatus Regenertv Tchnlgy Inc160.00k-8.08m35.07m10.00--195.26--219.20-0.5824-0.58240.01150.01260.0474----16,000.00-239.52-330.30-507.69-1,524.8877.50---5,053.13-35,138.840.2558--0.7407-------44.28---39.07--
BioRegenx Inc22.24k-571.17k35.40m10.00------1,591.52-0.0021-0.00210.00008-0.00080.4899----2,224.00-1,258.22------96.85---2,568.21-----13.2366.29---47.25---629.37------
iCAD Inc17.94m-5.14m38.48m67.00--1.18--2.15-0.1982-0.08940.69151.230.40810.91992.47267,731.30-11.70-23.94-14.93-34.1485.6076.96-28.66-45.024.59--0.00---12.54-7.5329.32--23.88--
electroCore, Inc.18.69m-16.47m38.62m68.00--8.59--2.07-2.85-2.853.130.74861.161.3054.34274,897.10-102.35-70.73-177.94-88.9682.7075.81-88.12-352.821.18--0.00--86.5774.4215.02---5.88--
Precision Optics Corporation Inc19.41m-1.64m39.02m84.00--3.47--2.01-0.2706-0.27063.241.861.064.304.51231,098.50-8.98-6.71-13.18-10.5533.6533.65-8.43-5.021.05-8.860.1982--34.2339.1284.42--19.39--
IRIDEX Corp49.92m-10.94m39.49m111.00--6.09--0.7911-0.6759-0.67593.080.39921.332.667.42449,765.80-29.16-19.54-47.74-27.4640.7242.67-21.92-15.451.03--0.00---8.964.02-26.81---24.35--
Inspira Technologies Oxy BHN Ltd0.00-11.29m39.77m37.00--6.27-----0.9549-0.95490.000.36660.00----0.00-88.60-114.98-108.36-159.56------------0.00------24.64------
DarioHealth Corp19.04m-59.90m42.79m276.00--0.5395--2.25-2.04-2.040.6332.650.15552.343.5769,000.00-43.90-73.26-51.33-87.5927.5629.54-282.38-293.542.67--0.2673---26.4122.450.5091--52.42--
Autonomix Medical Inc0.00-10.68m42.85m3.00---------0.5055-0.50550.00-0.2649------0.00----------------------------84.50------
Cutera Inc196.64m-157.56m43.16m430.00------0.2195-7.89-7.899.86-9.600.48642.294.43457,293.00-38.97-22.00-50.24-30.7216.4247.63-80.13-27.242.22-43.941.84---15.865.47-97.76--85.87--
Vaso Corp80.54m3.18m44.52m300.0012.271.7410.890.55280.02070.02070.45890.14591.1620.037.77268,470.004.577.607.4416.6261.8358.393.955.821.37--0.0091--2.181.84-57.46---22.33--
Lucid Diagnostics Inc2.98m-54.53m46.41m70.00------15.56-1.27-1.270.06980.25440.0735--78.5042,614.29-115.88---248.82---111.06---1,576.63--1.36--0.5579--544.03--6.24------
Envoy Medical Inc297.00k-22.43m46.45m34.00------156.40-2.21-2.210.0194-0.37820.04940.47372.368,735.29-381.38---2,885.46---118.18---7,718.86--0.8969-16.54----33.33---87.83------
Data as of May 31 2024. Currency figures normalised to Inspira Technologies Oxy BHN Ltd's reporting currency: US Dollar USD

Institutional shareholders

0.54%Per cent of shares held by top holders
HolderShares% Held
IEQ Capital LLCas of 31 Mar 202451.95k0.30%
Citadel Securities LLCas of 31 Mar 202418.85k0.11%
CIBC World Markets, Inc.as of 31 Mar 202415.00k0.09%
Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Mar 20246.51k0.04%
BFSG LLCas of 31 Mar 2024650.000.00%
BofA Securities, Inc.as of 31 Mar 202492.000.00%
Virtu Americas LLCas of 31 Mar 20240.000.00%
Armistice Capital LLCas of 31 Mar 20240.000.00%
UBS Securities LLCas of 31 Mar 20240.000.00%
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.